These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 5420434)

  • 41. Possible involvement of fibrinogen and proteolysis in surface activation. A study with the recording ellipsometer.
    Vroman L; Adams AL
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):510-24. PubMed ID: 4232164
    [No Abstract]   [Full Text] [Related]  

  • 42. [Epsylon-aminocaproic acid in the treatment of severe and dominating hyperfibrinolysis in a premature infant].
    Schmidt B; Pringsheim W; Künzer W
    Helv Paediatr Acta; 1980 Jul; 35(3):273-9. PubMed ID: 6773909
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Early local and systemic fibrinolytic response to high energy missile trauma.
    Almskog B; Risberg B; Teger-Nilsson AC; Seeman T
    Acta Chir Scand Suppl; 1982; 508():327-36. PubMed ID: 6177148
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Blood-aqueous barrier changes during activation of fibrinolysis in plasma].
    Rudobielski R
    Klin Oczna; 1974 Feb; 44(2):129-33. PubMed ID: 4453093
    [No Abstract]   [Full Text] [Related]  

  • 45. Preparation of human fibrinogen free from plasminogen by an immunochemical technique.
    Ohlsson K
    Clin Chim Acta; 1969 Aug; 25(2):221-4. PubMed ID: 5816600
    [No Abstract]   [Full Text] [Related]  

  • 46. [Activation and inhibition of buffy crust fibrinolysis in vitro].
    Harms D
    Gegenbaurs Morphol Jahrb; 1968; 111(3):488-92. PubMed ID: 4232858
    [No Abstract]   [Full Text] [Related]  

  • 47. Measurement during fibrinolytic therapy.
    McNicol GP
    Proc R Soc Med; 1969 Nov; 62(11 Part 1):1131-3. PubMed ID: 5356869
    [No Abstract]   [Full Text] [Related]  

  • 48. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH; Diamond SL
    Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fibrinolytic activation of plasma by means of urokinase in vitro and in vivo.
    Nanninga LB; Guest MM
    Thromb Diath Haemorrh; 1970 Oct; 24(1):33-42. PubMed ID: 5483972
    [No Abstract]   [Full Text] [Related]  

  • 50. Effect of heparin and AMCA on coagulation and fibrinolysis in blood and lymph following massive haemorrhage in dogs.
    Leandoer L; Bergentz SE; Nilsson IM
    Acta Chir Scand; 1969; 135(1):1-6. PubMed ID: 5805939
    [No Abstract]   [Full Text] [Related]  

  • 51. Proteolytic activity of the activator produced by streptokinase in human plasma.
    Claeys H; Amery A; Verhaeghe R
    Thromb Diath Haemorrh; 1971 Aug; 26(1):88-98. PubMed ID: 4255825
    [No Abstract]   [Full Text] [Related]  

  • 52. Description of new fibrinolytic enzyme, isolated from the haemolymph of Rhodnius prolixus Stal (Heteroptera Reduviidae).
    Ben Hamouda MH; Soria J; Soria C
    Arch Inst Pasteur Tunis; 1982; 59(2-3):251-68. PubMed ID: 6762857
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Permeability of the blood-aqueous barrier during inhibition of fibrinolysis in blood serum].
    Rudobielski R
    Klin Oczna; 1974 Mar; 44(3):239-42. PubMed ID: 4822124
    [No Abstract]   [Full Text] [Related]  

  • 54. [Effect of a single administration of plasminogen tissue activator on the state of the fibrinolytic system of rat blood].
    Andreenko GV; Shimonaeva EE; Liutova LV; Serebriakova TN
    Vopr Med Khim; 1981; 27(1):77-80. PubMed ID: 7193381
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effects of infusing thrombin and its acetylated derivative. I. Studies of coagulation and fibrinolysis.
    Pechet L; Engel AM; Goldstein C; Glaser B
    Thromb Diath Haemorrh; 1968 Nov; 20(1):190-201. PubMed ID: 5751381
    [No Abstract]   [Full Text] [Related]  

  • 56. Synthesis and activity of N alpha-(epsilon-aminocaproyl)-alanines and N epsilon-(epsilon-aminocaproyl)-caproic acid.
    Midura-Nowaczek K; Bruzgo I; Popławski J; Roszkowska-Jakimiec W; Worowski K
    Acta Pol Pharm; 1995; 52(6):505-7. PubMed ID: 8960269
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The evaluation of plasmin and streptokinase activator complexes in a new rabbit model of venous thrombosis.
    Dupe RJ; English PD; Smith RA; Green J
    Thromb Haemost; 1981 Aug; 46(2):528-34. PubMed ID: 6458112
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Therapy with fibrinogen].
    Egli H
    Hamatol Bluttransfus; 1968; 5():20-8. PubMed ID: 4239552
    [No Abstract]   [Full Text] [Related]  

  • 59. [Quantitative determination of fibrinolytic degradation products by means of electroimmunodiffusion].
    Frick U; Friemel H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(5):826-32. PubMed ID: 4140822
    [No Abstract]   [Full Text] [Related]  

  • 60. Fibrinogen turnover after massive haemorrhage in heparinized dogs.
    Leandoer L; Appelgren L; Bergentz SE
    Eur Surg Res; 1969; 1(2):115-25. PubMed ID: 5406435
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.